Chemspec International Limited

Management

Home > Introduction

Dr.Jianhua Yang, Chairman and CEO
Dr. Jianhua Yang, has been chairman and chief executive officer of Shanghai ChemSpec since he founded it in 1996. Dr. Yang has more than 20 years of experience in fluorinated specialty chemicals. Dr. Yang graduated from the Shanghai Institute of Organic Chemistry of the Chinese Academy of Sciences with a Ph.D. in science in 1988. In 1991, Dr. Yang was awarded with the National Natural Science Award (First Class) by the Chinese Academy of Sciences and in 1993, was awarded with the National Natural Science Award (Second Class) by the State Commission on Science and Technology of China.

Dr.David Yunhung Tang, Executive Vice President
Dr. David Yunhung Tang has worked for Shanghai ChemSpec as executive vice president of marketing and research and development since 2001. Dr. Tang is responsible for overseeing our research and development and marketing activities. Dr. Tang has more than 30 years of experience in fluorinated specialty chemicals, having worked in a range of positions for Occidental Chemical Corporation, Buffalo, New York, from 1977 to 2000, including research scientist, technology group leader, technical manager, senior manager, general manager of a joint venture of Occidental Chemical Corporation and research fellow. In 1973, he obtained a Ph.D. from Indiana University, USA. In 1985, he obtained an MBA degree from the State University of New York at Buffalo, USA, and in 1987 he completed an Executive Management program at Northeastern University.

Mr.Bing Zhu, CFO
Mr. Bing Zhu was appointed our chief financial officer in June 2008. From May 2006 until June 2008, he was chief financial officer of Canadian Solar Inc., a Nasdaq-listed solar cell and module products manufacturer based in China. From March 2005 until May 2006, he was financial controller and acting chief financial officer of Canadian Solar Inc. Prior to that, Mr. Zhu was a commercial banking relationship account manager at Royal Bank of Canada. From May 1996 to June 2000, Mr. Zhu worked as the Shanghai chief representative of Raytheon Corporation and was in charge of market development for its commercial electronics, engineering & construction and commercial aircraft divisions in China. From 1993 to 1996, he was a corporate banking account manager for Banque Indosuez. His customers included the China operations of European- and North Americanbased multi-national companies as well as B- and H- share Chinese public companies. From 1986 to 1992, Mr. Zhu was an accountant and then a finance manager in a Chinese state-owned enterprise in Hangzhou, China. Mr. Zhu received his bachelor’s degree in business management in 1986 from Zhejiang University of Technology in China, and his MBA degree in 1993 from China Europe International Business School (previously known as China-Europe Management Institute).

Peter H.C.Shu , Senior Vice President
Dr. Shu joins Chemspec with over 30 years of experience in marketing, sales, technology and management in multinational chemical companies in the United States, Hong Kong and Taipei. Most recently, Dr. Shu served as Global Marketing Manager in the Plastics Additives Business of Rohm and Haas, which is now a wholly owned subsidiary of the Dow Chemical Company. In this position, he directed a global strategic marketing and sales team. He also developed and implemented a global marketing and sales strategy. Prior to Rohm and Haas, Dr. Shu held a variety of roles with increasing responsibilities at Bayer AG from 1985 to 2005. He contributed significantly to the fast and profitable growth of various Bayer companies through his leadership in marketing and new business development, which included a number of strategic alliances and joint ventures. Dr. Shu holds a Ph.D. in Polymer Chemistry from Rensselaer Polytechnic Institute, an MBA from the State University of New York at Albany, an M.S. in Organic Chemistry from the Ohio State University, and a B.S. in Chemistry from National Taiwan University. Dr. Shu has nine patents and 17 publications.

Mr.Wujun Yang, Vice President
Mr. Wujun Yang, our vice president, is responsible for overseeing the construction of facilities and purchase of raw materials. Mr. Yang has worked for Shanghai ChemSpec since 1997. Mr. Yang has more than 30 years of experience in the manufacturing of chemicals. Mr. Yang graduated from the East China University of Science & Technology, majoring in chemical engineering in 1977. Prior to joining our Group, he served as an engineer with the Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences from 1986 to 1996.

Mr.Matthew X.Yang, Vice President
Mr. Matthew X.Yang is our vice president responsible for overseeing our marketing activities and has helped develop our business with pharmaceutical customers. He joined Shanghai ChemSpec in May 2006. Mr. Yang has more than 10 years of experience in pharmaceutical operations. Mr.Xiaosong Yang received a Bachelor’s Degree of Medicine in Forensic Medicine in 1996 from the Shanghai Medical University (currently Shanghai Medical College of Fudan University) in China, and a master of science in information systems in 2003 from Northeastern University in the U.S. He is pursuing an EMBA degree from China Europe International Business School. Between 2003 and 2006, Mr. Yang was a general manager of the Business Department at Summit Pharmaceuticals (China) Ltd., responsible for new drug development projects and new business development for both the European and the US markets. Between 2002 and 2003, he was an independent contractor with CoreStreet, Ltd. Between 1996 and 2000, he worked in business development and sales at Sumitomo Corporation (Shanghai) Ltd.

Mr. Yunlong Yuan, Vice President
Mr. Yunlong Yuan is our vice president responsible for overseeing our manufacturing processes and operations. From 1998 to 2007, he was a director of research and development for Shanghai ChemSpec and was responsible for overseeing the research and development activities of Shanghai ChemSpec jointly with Dr. Tang. Mr. Yuan has more than 10 years of experience in fluorinated specialty chemicals. Mr. Yuan graduated from the chemistry department of East China University of Science and Technology majoring in industrial catalysis in 1996. Prior to joining our Group, he served as a technician with Nanjing Chemical Industrial (Group) Co., Ltd.

Mr.Zixin Wang, Vice President
Mr. Zixin Wang is our vice president responsible for administration and human resources. From 2006 to 2007, he was the financial controller of Shanghai ChemSpec. Prior to joining us, he served as a project manager of Shanghai Boning Finance Advisory Limited, where he was responsible for advising on offshore initial public offerings of Chinese companies and investment activities in China of foreign companies. In 2004, he obtained his master’s degree in accounting from Shanghai Jiaotong University.

Dr. Jinhua (Jim) Chen, Vice President
Dr. Jinhua (Jim) Chen, VP of R&D, oversees process research and development at Chemspec. He joined Chemspec in June 2008, and was the Director of R&D for a year before the promotion. Prior to Chemspec, Dr. Chen was an associate research investigator in the global pharmaceutical research and development division at Abbott Laboratories in Chicago, Illinois. Dr. Chen was also an American Chemical Society Industrial Innovation Award winner and a member of the teams at Abbott Laboratories which launched the drugs Ritonavir and Lopinavir. He holds a Ph.D. in organometallic chemistry from the University of New Brunswick in Canada and a B.S. in organic chemistry from Xiamen University in the People’s Republic of China.

Yuelie Lu, Ph.D., Vice President
Dr. Yuelie Lu joined Shanghai Chemspec Corporation in June of 2009 as the Vice President. Dr. Lu has extensive experience in pharmaceutical chemical process research and development, project management, and CMC management. Prior to joining Chemspec, Dr. Lu held a broad range of responsibilities at multiple pharmaceutical companies in the United States, with his two most recent positions being an associate director of chemical development at Lexicon Pharmaceuticals in New Jersey and a principle scientist at Amgen Inc. in California. Dr. Lu holds a Ph.D. from Purdue University in Indiana and a B.S. and M.S. from the University of Science & Technology of China.